Rinvoq®

Rinvoq (generic name: upadacitinib) is a prescription oral tablet medicine that can be prescribed for adults after treatment for one of the following conditions with a TNF (tumor necrosis factor) blocker has been tried, and either did not work well or could not be tolerated:

– moderate to severe rheumatoid arthritis (RA)
– active psoriatic arthritis (PsA)
– moderate to severe ulcerative colitis (UC)
– active ankylosing spondylitis (AS)
– active non-radiographic axial spondyloarthritis (nr-axSpA)

As well, it can be prescribed for adults and children over the age of 12 with moderate to severe eczema (atopic dermatitis) that did not respond to previous treatment and whose eczema is not well controlled with other pills or injections,

There are also current studies of the off-label prescription of Rinvoq for patients with Crohn’s Disease.